title: [Features of hemocomponental therapy in oncological patients].
abstract: The authors present an analysis of specific features of transfusions of erythrocyte containing media in oncological patients. Special attention was given to necessary selection of donor erythrocytes in performing operations with massive intraoperative blood loss. It considerably contributes to a decreased number of posttransfusional reactions and complications. For the recent five years transfusions of erythrocyte containing media to more than 15 thousand patients with surgical treatment were analyzed. Among them the individual selection of donor blood was fulfilled in 2047 cases. Compatible erythrocytes could not be selected in five cases only. In these patients infusions of Perftoran were used as an oxygen carrier both during operation and at the postoperative period.
authors.forename: G A
authors.initials: GA
authors.lastname: Sofronov
authors.forename: M D
authors.initials: MD
authors.lastname: Khanevich
authors.forename: G M
authors.initials: GM
authors.lastname: Manikhas
authors.forename: A S
authors.initials: AS
authors.lastname: Lisianskaia
authors.forename: E A
authors.initials: EA
authors.lastname: Selivanov
authors.forename: A V
authors.initials: AV
authors.lastname: Feofanova
authors.forename: R V
authors.initials: RV
authors.lastname: Fadeev
authors.forename: M A
authors.initials: MA
authors.lastname: Giparovich
authors.forename: N N
authors.initials: NN
authors.lastname: Pshenkina
authors.forename: M S
authors.initials: MS
authors.lastname: Dinikin
mesh_terms: D000328:Adult; D000740:Anemia / Q000097:blood / Q000209:etiology / Q000628:therapy; D016913:Blood Component Transfusion / Q000379:methods* / Q000592:standards; D001782:Blood Donors; D001789:Blood Group Antigens / Q000032:analysis; D001787:Blood Group Incompatibility / Q000517:prevention & control*; D016063:Blood Loss, Surgical; D001802:Blood Substitutes / Q000008:administration & dosage; D004921:Erythropoietin / Q000008:administration & dosage; D005260:Female; D005466:Fluorocarbons / Q000008:administration & dosage; D006680:HLA Antigens / Q000032:analysis; D006397:Hematinics / Q000008:administration & dosage; D006650:Histocompatibility Testing; D006801:Humans; D008297:Male; D008875:Middle Aged; D008991:Monitoring, Physiologic; D009369:Neoplasms / Q000150:complications* / Q000601:surgery; D058996:Quality Improvement; D011994:Recombinant Proteins; D012189:Retrospective Studies
chemical_list: D001789:Blood Group Antigens; D001802:Blood Substitutes; D005466:Fluorocarbons; D006680:HLA Antigens; D006397:Hematinics; D011994:Recombinant Proteins; D004921:Erythropoietin; C063334:perftoran